Press Releases - WDM Group PR Network

Novo Nordisk A/S: Tresiba(R) (insulin degludec) approved in Japan

Media: Mike Rulis Tel: (+45) 3079 3573 Email Contact In North America: Ken Inchausti Tel: (+1) 609 514 8316 Email Contact Investors: Kasper Roseeuw Poulsen Tel: (+45) 4442 4303 Email Contact Frank Daniel Mersebach Tel: (+45) 4442 0604 Email Contact Lars Borup Jacobsen Tel: (+45) 3075 3479 Email Contact Jannick Lindegaard Tel: (+1) 609 786 4575 Email Contact

Life Science Incubators and Accelerators Gain Traction With $523 Million in Construction Starts, an Industrial Info News Alert

Contact:
Joe Govreau
713-783-5147

Biotech Industry Applauds Introduction of the High Technology Small Business Research Incentives Act

Contact:
Five Star Equities
Email Contact

Biotech Industry Look to Benefit From the Introduction of the High Technology Small Business Research Incentives Act

Contact:
Five Star Equities
Email Contact

Immunovative, Inc. Moves Corporate Headquarters to Danbury, Connecticut Effective October 01, 2012

For more information please contact:

Mr. Seth M. Shaw
Chairman & Chief Executive Officer
Immunovative, Inc. (OTCQB: IMUN)
New York: +1-917-796-9926
Montreal: +1-514-840-3697
Email: Email Contact

Prana Scientist to Participate in Webcast to Discuss Alzheimer's Disease Therapeutics: Recent Setbacks and Emerging Technologies on Monday, October 1

Contacts:
Australia
Prana Biotechnology
+61 3 9349 4906

US
Leslie Wolf-Creutzfeldt
T: 646-284-9472
E: leslie.wolf-creutzfeldt@grayling.com

Critical Outcome Technologies Inc. Delivering Podium Presentation on New Mechanism of Action Data for COTI-2

Critical Outcome Technologies Inc.
Dr. Wayne Danter
President and CEO
wdanter@criticaloutcome.com
www.criticaloutcome.com

Novo Nordisk A/S: Novo Nordisk Discontinues Development of Vatreptacog alfa Following Analysis of Phase 3 Results

Novo Nordisk A/S Novo Alle, DK-2880 Bagsvaerd, Danmark T. Tlf. +45 44 44 88 88 F. Fax +45 44 44 49 05

Early Warning Report Issued Pursuant to National Instrument 62-103 in Respect of the Acquisition of Shares of Abattis Bioceuticals Corp.

Michael Withrow
21141 80B Avenue
Langley, BC V2Y 0J5

Mastectomy Lingerie and More Continues to Give Back by Giving Away 100 Post-Surgery Camisoles

Who to contact: Mastectomy Lingerie and More
Sue Teschke
Owner, Survivor, Certified Fitter
289-689-5409
info@mlam.ca
www.mlam.ca
or
Who to contact: Breast Cancer Support Services
Blair Lancaster
Executive Director
905-634-2333
blancaster@breastcancersupport.org
www.breastcancersupport.org

Prev | ... 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | 100 | 101 | 102 | 103 | 104 | 105 | 106 | 107 | 108 | 109 | 110 | 111 | 112 | 113 | 114 | 115 | 116 | 117 | 118 | 119 | 120 | 121 | 122 | 123 | 124 | 125 | 126 | 127 | 128 | 129 | 130 | 131 | 132 | 133 | 134 | 135 | 136 | 137 | 138 | 139 | 140 | 141 | 142 | ...Next

Press Releases - WDM Group PR Network

Novo Nordisk A/S: Tresiba(R) (insulin degludec) approved in Japan

Life Science Incubators and Accelerators Gain Traction With $523 Million in Construction Starts, an Industrial Info News Alert

Biotech Industry Applauds Introduction of the High Technology Small Business Research Incentives Act

Biotech Industry Look to Benefit From the Introduction of the High Technology Small Business Research Incentives Act

Immunovative, Inc. Moves Corporate Headquarters to Danbury, Connecticut Effective October 01, 2012

Prana Scientist to Participate in Webcast to Discuss Alzheimer's Disease Therapeutics: Recent Setbacks and Emerging Technologies on Monday, October 1

Critical Outcome Technologies Inc. Delivering Podium Presentation on New Mechanism of Action Data for COTI-2

Novo Nordisk A/S: Novo Nordisk Discontinues Development of Vatreptacog alfa Following Analysis of Phase 3 Results

Early Warning Report Issued Pursuant to National Instrument 62-103 in Respect of the Acquisition of Shares of Abattis Bioceuticals Corp.

Mastectomy Lingerie and More Continues to Give Back by Giving Away 100 Post-Surgery Camisoles

Most Popular + More Most Popular >>

From Partners + More From Partners >>

LATEST VIDEOS + More LATEST VIDEOS >>

Associations + MORE Associations >>

Reports + More Reports >>